Product Details of 'Leflunomide Related Compound B' |
Catalog Number |
DI-T-04169 |
Category |
Impurities |
CAS Number |
108605-62-5 |
Molecular Weight |
270.21 |
Molecular Formula |
C12H9F3N2O2 |
Application Notes |
"rac A77 1726 is the active metabolite of Leflunomide, a potent disease-modifying antirheumatic drug used in the treatment of rheumatoid arthritis. LEF-M interferes with dendritic cell function. The second Phase III study evaluating the efficacy of Genzyme’s teriflunomide therapy against relapsing forms of multiple sclerosis found the once-daily oral drug to be no less effective than injectable interferon beta 1a (Rebif®). " |
References |
"Kirsch, B,M,, et al,: Arthritis Research and Therapy, 7, 3, R694, (2005)" |
|
|
|
Leflunomide Related Compound B
Keywords:Impurities of Leflunomide,Impurity of Leflunomide,Leflunomide impurities, Cas no 108605-62-5,Analytical Standards of Leflunomide,Leflunomide EP Impurities,
This page contains
information about
Impurities of
Leflunomide Related Compound B with CAS
108605-62-5
For more information about
Leflunomide or
Leflunomide Related Compound B write to
us at
[email protected] |